Abstract | The outcome of an infection with any given pathogen varies according to the dosage and route of infection, but, in addition, the physiological state of the host can determine the efficacy of clearance, the severity of infection and the extent of immunopathology. Here we propose that the forkhead box O (FOXO) transcription factor family -which is central to the integration of growth factor signalling, oxidative stress and inflammation -provides connections between physical well-being and the form and magnitude of an immune response. We present a case that FOXO transcription factors guide T cell differentiation and function in a context-driven manner, and might provide a link between metabolism and immunity.
The signal transduction of metazoans seems to be both complex beyond understanding and simple, in that a limited number of pathways, which are conserved across vast evolutionary time, control most cell fate decisions. Many of these signalling pathways were first traced in yeast, worms, flies or dedifferentiated cells in tissue culture, and this has provided a starting point for understanding cellular and organismal responses to environmental change. We imagine that with increasing organismal complexity, new differentiated cell types arose, and the fundamental signalling pathways of single-cell organisms were redirected to integrate new inputs and compute selectable, advantageous results. Thus, similarly rooted pathways in different cell types may or may not serve a common purpose or programme of gene expression.
Forkhead box O (FOXO) transcription factors are central to many aspects of metazoan physiology
. They are named for their forkhead domain, a DNAbinding domain of ~100 amino acids, and for their membership of the O subclass 1 . They regulate cell-cycle progression, DNA repair and apoptosis and, as such, are considered to be tumour suppressor proteins [2] [3] [4] [5] . They also respond to oxidative stress and regulate ageing, in part through the detoxification of reactive oxygen species and the control of DNA repair pathways 6, 7 . Furthermore, they affect metabolism and the anerobic or aerobic generation of ATP at multiple control points 8 . More recently, FOXO1 was shown to control a programme of pluripotency in human and mouse embryonic stem cells, probably by directly controlling the transcriptional activity of OCT4 (also known as POU5F1) and SOX2 (REF. 9 ). It is possible, although not proven, that most if not all cell fates are in some manner regulated by FOXO transcription factors. This great variety of cellular functions seemingly directed by FOXO transcription factors illustrates the principle that individual transcription factors do not determine cell-type specification. Rather, a given transcription factor functions as a scaffold that is post-transcriptionally modified as a result of cellular context, and thus common signalling modules direct different programmes of gene expression. No gene is always activated by a given transcription factor, and conversely there is no circumstance under which a transcription factor activates every one of its target genes 10 . Specifically, the expression of a FOXO transcription factor itself is not predictive of a cellular function or state of differentiation; rather, it enables the amplification of cellular potential. It can provide an integration point for several inputs and induce distinct programmes of gene expression while retaining conserved mechanisms and pathway connections.
As reviewed extensively elsewhere [11] [12] [13] [14] , and briefly below, FOXO transcription factors respond to growth factors, oxidative stress, inflammation and nutritional abundance -physiological conditions that influence the magnitude and effectiveness of an immune response. In turn, FOXO transcription factors regulate cell survival, division and energy utilization, and these activities of FOXO transcription factors would be predicted to strongly affect the expansion and contraction of antigen-responsive lymphocyte populations.
Tumour suppressor proteins
Proteins that limit the generation of cancer. Many of these proteins regulate scheduled entry to the cell cycle or promote the apoptosis of damaged cells. Loss-of-function mutations in tumour suppressor genes increase susceptibility to cancer.
Reactive oxygen species
Highly reactive oxygen-containing molecules that can be produced by the mitochondria in eukaryotic cells. Examples include hydrogen peroxide, ions such as hypochlorite, and free radicals such as superoxide and nitric oxide. They can be inactivated by enzymes such as superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase.
mTORC2
(Mammalian target of rapamycin complex 2). A complex consisting of: mammalian target of rapamycin (mTOR); rapamycininsensitive companion of mTOR (RICTOR); mammalian stress-activated MAP kinaseinteracting protein 1 (mSIN1; also known as MAPKAP1); protein observed with RICTOR 1 (PROTOR1); PROTOR2; DEP domaincontaining mTOR-interacting protein (DEPTOR); and mLST8 (also known as GβL).
MDM2
An E3 ubiquitin ligase that can cause the proteasomal degradation of p53 as well as of other tumour suppressor proteins such as FOXO3.
In addition, more recent work has shown that FOXO transcription factors have been co-opted to regulate specialized characteristics of lymphocyte homeostasis, including turnover, homing and differentiation 12, [15] [16] [17] . In this Review, we address the possibility that FOXO transcription factors programme lymphocytes to respond to diverse physiological changes, some of which are advantageous whereas others may contribute to immune pathology. We also highlight recent work showing that FOXO transcription factors are central to multiple processes of T cell differentiation, including the formation of memory T cells. The study of FOXO transcription factors now affords an opportunity to begin to understand the integration of immunity with the physiological state of an organism, which includes metabolic function, inflammation and oxidative stress.
Control of FOXO transcriptional activity
Cell type-specific expression. FOXO paralogues are expressed widely, although each has a unique pattern of tissue-specific expression. Several transcription factors have been shown to directly affect the expression of FOXO genes. Such factors include FOXC1, E2F1, p53, E2A, HEB (also known as TCF12) and, interestingly, FOXO1 and FOXO3 themselves, implying a positive-feedback control mechanism [18] [19] [20] . Through such feedback, post-translational inhibitory modifications to FOXO transcription factors (as discussed below) could reduce the transcription of FOXO genes. The transcriptional basis for the preferential expression of FOXO1 in lymphocytes is not understood, but signal transducer and activator of transcription 3 (STAT3) seems to bind to the promoters of Foxo1 and Foxo3, and Stat3 −/− naive T cells have low levels of both Foxo1 and Foxo3 mRNA 21 . In the determination of B cell fate, E2F1 and E2A have been shown to bind to the Foxo1 locus 22 . Currently, the field awaits a comprehensive analysis of the general and lymphocyte-specific promoter and enhancer binding sites that are active in the Foxo1 and Foxo3 genes.
Post-translational modifications. FOXO transcription factors are subject to extensive and varied posttranslational modifications that affect their abundance, localization and transcriptional activity. Together these modifications have been described as a FOXO code 11, 13 . Such modifications have been found in various cell types, but, although they are assumed to be generally applicable, they have not been extensively studied in T cells.
A major pathway of FOXO regulation is initiated by growth factors, such as insulin, and results in the activation of phosphoinositide 3-kinase (PI3K) (FIG. 1) . The activity of PI3K causes the recruitment of the kinases AKT and SGK1 to the cell membrane and their phosphorylation by 3-phosphoinositidedependent kinase 1 (PDK1) 23, 24 . AKT and SGK1 can directly phosphorylate FOXO transcription factors on three sites, but to mediate this activity they must also be phosphorylated by mTORC2 (REFS [25] [26] [27] . Until recently, the activation requirements for mTORC2 were not understood, but a genetic screen in yeast followed by studies in mammalian cell lines have shown that PI3K enhances a (translation-independent) inter action between mTORC2 and the ribosome, and it is this interaction that allows mTORC2 to phosphorylate AKT within its hydrophobic motif (at S473) 28 . The result of the triple phosphorylation of FOXO transcription factors by AKT or SGK1 (at T24, S256 and S319) (FIG. 2) is nuclear export and degradation 7, 29, 30 , and this basic mechanism is conserved across all the phyla that have been examined 31 . This mechanism is partially mimicked by cyclin-dependent kinase 2 (CDK2), which is important for the transition from G1 phase to S phase in the cell cycle and which has been shown to phosphorylate FOXO1 at S249 to induce nuclear export. This export presumably promotes cell survival during cell-cycle progression, and it is abrogated by DNA damage in a p53-independent manner 32 . The inhibitory mechanism mediated by AKT or SGK1 functions in T cells stimulated through the T cell receptor (TCR), common γ-chain (γ c ) cytokine receptors or homing receptors 2, 3, [33] [34] [35] . An additional growth factor-controlled inhibitory pathway is mediated through the phosphorylation of FOXO3 at three unique sites by extracellular signalregulated kinase (ERK) (FIG. 2) , and this results in MDM2-mediated ubiquitylation and proteosomal degradation of FOXO3 (REF. 36 ). This pathway also seems to operate in T cells. Under conditions of regulatory T (T Reg ) cell differentiation, deletion of Erk2 resulted in a threefold or greater increase in the expression of 20 genes, and three of these genes were direct FOXO1 targets: interleukin-7 receptor subunit-α (Il7ra), L-selectin (Sell) and Krüppel-like factor 2 (Klf2) 37 . Similarly to growth factors, pro-inflammatory cytokines -such as tumour necrosis factor (TNF) -can also affect the
Box 1 | The FOXO transcription factor family
In jawed vertebrates, possibly excluding cartilaginous fish, there are four major forkhead box O (FOXO) paralogues that are orthologous to the single-copy genes found in urochordates, nematodes (in which this gene is known as daf-16) and arthropods (in which this gene is known as foxo). The four paralogues arose from an initial duplication event that produced the FOXO1/FOXO4 gene lineage and the FOXO3/FOXO6 gene lineage, followed by a second pair of duplication events that produced the four separate, unlinked genes: FOXO1, FOXO3, FOXO4 and FOXO6 (REF. 165 ). FOXO1, FOXO3 and FOXO4 are widely expressed, and the encoded proteins have many of the same post-translational regulatory mechanisms. By contrast, FOXO6 is largely expressed in the nervous system and is the most diverged evolutionarily, and the protein it encodes is subject to alternative mechanisms of post-translational regulation 165, 166 . In mammals, FOXO1 is most highly expressed in B cells, T cells and ovaries 66 , although genetic analyses have shown it to have an important function in many tissues 5, 167 . Foxo1-mutant mice exhibit embryonic lethality at embryonic day 10.5 owing to impaired vascular development 168, 169 . FOXO3 expression is found in most tissues, including lymphocytes and myeloid cells, and Foxo3-mutant mice are largely without a noticeable phenotype with the exception that female mice exhibit early depletion of functional ovarian follicles 168, 170 . One mouse strain with an insertional mutation in Foxo3 seemed to develop spontaneous immunopathology 15 ; however, this was not apparent in two other Foxo3-mutant strains 43, 168, 170 . FOXO4 is similarly expressed across human tissues at an apparently low level 66 . Mice with loss-of-function mutations in Foxo4 have no known phenotypic differences from wild-type mice. course of an immune response, and a central inflammatory pathway results in the nuclear localization of nuclear factor-κB (NF-κB) through the activity of IκB kinase (IKK) 38, 39 . Studies have shown that IKK is the key survival factor for acute myeloid leukaemia (AML) blast cells 40, 41 , and it functions through the inactivation of FOXO3 (REF. 42 ). An implication is that inflammatory processes, however they are induced, inactivate FOXO3 (through increased IKK activity), and this could affect T cell or dendritic cell (DC) function (as described later) 15, 43 . Another mode of FOXO turnover may be regulated by GTPases of the immunityassociated protein family (GIMAPs), which are associated with human autoimmunity [44] [45] [46] . T cells from mice with a mutation in Gimap5 displayed a progressive loss of FOXO1, FOXO3 and FOXO4 and a concomitant loss of T Reg cell function 47 . The authors speculated that GIMAP5 regulates the turnover of FOXO transcription factors through an increase in the expression of S-phase kinase-associated protein 2 (SKP2) and thus proteasomal degradation.
In opposition to these FOXO-inhibitory pathways is oxidative stress, the effects of which are propagated through several post-translational FOXO modifications. These include alternative phosphorylations by JUN N-terminal kinase (JNK) or mammalian STE20-like kinase 1 (MST1); both prevent the interaction of 14-3-3 scaffold proteins with FOXO transcription factors, thereby promoting FOXO nuclear localization 48, 49 . The JNK phosphorylation sites have been identified for FOXO4 but are not conserved in other paralogues; however, JNK also phosphorylates 14-3-3 proteins. As this too interferes with FOXO binding, one possibility is that JNK indirectly regulates the nuclear localization of all FOXO transcription factors 50 . In addition, arginine methylation of FOXO transcription factors by protein arginine N-methyltransferase 1 (PRMT1) inhibits AKTmediated phosphorylation at S256, thereby preventing AKT-mediated nuclear exclusion 51 . Oxidative stress can also affect p300-mediated acetylation and sirtuin 1 (SIRT1)-mediated deacetylation of FOXO transcription factors in a temporally complex manner 52, 53 . In some ; ataxia telangiectasia mutated (ATM) 176, 177 ; tuberous sclerosis protein 2 (TSC2) 178 ; extracellular signal-regulated kinase (ERK) 179 ; JUN N-terminal kinase (JNK) 180 ; mammalian STE20-like kinase 1 (MST1) 49, 181 ; IκB kinase (IKK) 42, 182 ; mammalian target of rapamycin (mTOR) 25 ; and CREB-binding protein (CBP) 183 . The mTOR pathway is inhibited in T cells by metformin, 5-aminoimidazole-4-carboxamide riboside (AICAR) 159 and rapamycin 160 . FOXO transcription factors also affect glycolysis 54 . γ c , γ-chain; 4EBP, EIF4E-binding protein 1; AMPK, AMP-activated protein kinase; BCL-6, B cell lymphoma 6; CTLA4, cytotoxic T lymphocyte antigen 4; EOMES, eomesodermin; IL-7Rα, interleukin-7 receptor subunit-α; KLF2, Krüppel-like factor 2; mTORC, mTOR complex; PDK1, 3-phosphoinositidedependent kinase 1; ROS, reactive oxygen species; S1P 1 , sphingosine-1-phosphate receptor 1; S6K1, S6 kinase 1; SIRT1, sirtuin 1; TCR, T cell receptor. cases, these modifications can supersede growth factormediated inhibition of FOXO transcriptional activity; however, we note that not all of these mechanisms have been verified in T cells. FOXO transcription factors in the liver are also regulated by nutrient levels and metabolic control mechanisms 54 . The energy sensor AMP-activated protein kinase (AMPK) enhances the transcriptional activity of FOXO3 directly through phosphorylation at six unique sites 55 , and indirectly through inhibition of the mTORC2 pathway 56 . In response to nutrient availability, FOXO transcription factors are also modified and activated by O-linked glycosylation with N-acetylglucosamine (GlcNAc), which is catalysed by a single enzyme, O-GlcNAc transferase. This modification functions as an energy sensor because it is highly sensitive to the concentration of the donor sugar, UDP-GlcNAc, which is the end product of the hexosamine biosynthetic pathway [57] [58] [59] . As the amount of UDP-GlcNAc is regulated by nearly every metabolic pathway, a prediction is that FOXO activity is responsive to the overall metabolic state of the cell. These modifications by AMPK and O-GlcNAc transferase have been described in liver, muscle and fat, but we still do not know how they control FOXO transcription factors in lymphocytes, macrophages or DCs. We also do not yet know how FOXO transcription factors integrate metabolism with T cell responses or the overall state of inflammation.
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miRNAs. FOXO transcription factors are also subject to post-transcriptional control by multiple microRNAs (miRNAs). For example, miR-27a, miR-96 and miR-182 decrease FOXO1 mRNA expression in breast cancer cells 60 . A contemporaneous report showed that melanoma metastasis depends on miR-182-mediated inhibition of FOXO3 expression 61 , whereas the expression of FOXO1 in endometrial cancer cells seems to be regulated by as many as five miRNAs 62 . In antigen-or mitogenstimulated mouse T cells, miR-182 is induced by IL-2 and decreases FOXO1 expression, allowing T cell proliferation to continue even after growth factor-induced, AKT-mediated inhibition of FOXO transcription factor activity wanes 63 . Conversely, inhibition of miR-182 causes increased levels of Foxo1 mRNA and decreased T cell proliferation secondary to increased cell death.
Another miRNA that potentially inhibits FOXO expression is miR-155. Studies have identified miR-155 as a signature of natural T Reg cells and have shown it to be important for targeting mRNAs encoding suppressor of cytokine signalling 1 (SOCS1), PU.1, MAF, activation-induced cytidine deaminase (AID), SH2 domain-containing inositol 5ʹ-phosphatase 1 (SHIP1) and interferon-γ (IFNγ) 64 . In addition, miR-155 targets Foxo3 transcripts in a T cell line and in mouse T cells 65 .
As genetic studies have shown that the dominant FOXO transcription factor in T cells is FOXO1 (REF. 66 ), we predict that dysregulation of FOXO3 expression in T cells through gain or loss of miR-155 would not be immediately discernable 43 . However, a recent report showed that loss of Foxo3 caused a twofold increase in the proliferation of CD8 + T cells in some tissues in response to infection with lymphocytic chorio meningitis virus 67 . This suggests that miR-155 could contribute to the regulation of T cell clonal expansion and memory. As FOXO1 and FOXO3 additively control the differentiation of T Reg cells 68, 69 , another possibility is that the balance between conventional T cells and T Reg cells is determined, in part, by miRNA-mediated post-transcriptional regulation.
Targets of FOXO transcriptional control
Direct DNA-binding transcriptional activity. The forkhead DNA-binding domain (also known as the winged-helix domain) of FOXO transcription factors is evolutionarily conserved and recognizes the sequence motif 5ʹ-GTAAA(T/C)AA-3ʹ (or 5ʹ-TT(A/G) TTTAC-3ʹ), which is known as the DAF-16 binding element (DBE) 70 (FIG. 3) . The actual recognition sequence is somewhat broader, however, as FOXO1 has a fivefold higher affinity for a DBE sequence that includes T-rich 3ʹ flanking sequences 71 . FOXO proteins also bind with lower affinity to the insulin response element (IRE), which has the sequence 5ʹ-(C/A)(A/C)AAA(C/T)AA-3ʹ (REFS 71, 72) . Specific acetylation or phosphorylation of FOXO1 was shown to inhibit or entirely preclude DNA binding, directly demonstrating that post-translational modifications affect the transcriptional function of FOXO transcription factors in addition to their intracellular localization 72 . FOXO transcription factors that are bound to DNA function as independent transcriptional activators, as deduced from their roles in oncogenesis 73, 74 . FOXO1 was originally identified as part of a fusion protein with paired box protein 3 (PAX3) resulting from a chromosomal translocation that is responsible for alveolar rhabdomyosarcoma 75 . The DNA-binding domain and thus target gene specificity was derived from PAX3, whereas the transcriptional activation domain came from FOXO1 (the reverse, which might enhance the gene expression programme of the FOXO1 tumour suppressor, would not be expected to lead to oncogenesis). Both FOXO3 and FOXO4 are also targets of chromosomal translocations in mixed-lineage leukaemias 76 ; the fusions mainly occur within and disrupt the FOXO DNA-binding domain, resulting in chimeric proteins that derive transcriptional activity from the FOXO factors. It would seem that the FOXO transactivation domains are particularly potent.
Other forms of transcriptional activity. FOXO transcription factors might also regulate transcription in a DNA-binding-independent manner, as mutant FOXO variants with inactivated DNA-binding domains were still able to regulate a subset of FOXO target genes 77 . A caveat is that these results were derived using an overexpressed and constitutively nuclear form of FOXO1 in PTEN-deficient cells. FOXO transcription factors also have chromatin binding and remodelling functions, endowing them with the ability to modulate active chromatin states 78 . In this regard, the transcriptional activity of FOXO transcription factors is often or always achieved by association with other transcriptional activators or repressors. FOXO transcription factors have been shown to associate with SMAD proteins, histone deacetylases and acetyltransferases, many nuclear hormones, β-catenin and other transcriptional regulators 79 . The mechanisms of co-regulation include direct binding interactions, sequestration and cooperative promoter binding sites (FIG. 3) . FOXO transcription factors in collaboration with other factors are thus able to integrate extrinsic information from many different pathways to coordinately initiate or facilitate varied programmes of transcriptional regulation. As stated above, the target genes of FOXO factors might be widely disparate in different tissues owing to differences in chromatin accessibility, available cofactors and post-translational modifications. Thus, our ability to extrapolate specific roles for FOXO transcription factors between different tissues is likely to be limited. (BOX 2) . Published studies show that several direct FOXO gene targets are actively transcribed in T cells. One important target is Il7ra 66, 68, 80 , which encodes IL-7Rα, a subunit of the primary survival receptor for naive T cells 81 . FOXO1 binds to an enhancer approximately 3 kb upstream of the Il7ra start site, and acute deletion of Foxo1 causes the loss of Il7ra expression in naive T cells 66 . A second important target is Klf2, which in turn controls the expression of Sell (which encodes L-selectin) and sphingosine-1-phosphate receptor 1 (S1pr1, which encodes S1P 1 ). These receptors are important for lymphocyte entry into and exit from lymphatic tissues 66, 82, 83 . In addition, FOXO transcription factors control Klf4, a tumour suppressor gene that is particularly active in B cells 84, 85 . As discussed below, FOXO transcription factors also directly regulate the expression of Foxp3 (REFS 86, 87) and cytotoxic T lymphocyte antigen 4 (Ctla4) 69 , which are essential for the differentiation and function of T Reg cells. Furthermore, there is evidence that FOXO transcription factors directly control the expression of B cell lymphoma 6 (BCL6) [88] [89] [90] , which encodes a transcriptional repressor that is required for the differentiation of CD4 + T follicular helper cells (T FH cells), B cells, T Reg cells, CD8 + T cells and natural killer T (NKT) cells [91] [92] [93] [94] [95] . In each case, BCL6-expressing cells have a tendency to localize to lymphoid follicles, and one of 
Control of T cell gene expression. The identification of FOXO target genes in T cells has depended on multiple avenues of investigation

CTLL cell line
A T cell line that grows indefinitely in the presence of interleukin-2 (IL-2) with no requirement for stimulation through the T cell receptor (TCR). This is not a feature of freshly explanted T cells, which require a cycle of TCR and IL-2 stimulation followed by rest before re-stimulation.
Electrophoretic mobility shift assay (EMSA). An assay used to measure DNA-protein interactions. Short stretches of double-stranded, radio-labelled DNA are mixed with nuclear extracts and subjected to sizing by gel electrophoresis. In the presence of bound proteins, the labelled DNA will migrate more slowly. To determine the identity of the bound proteins, specific antibodies can be added to see whether the migration of the complex is altered -either becoming even slower ('supershifted') or being prevented altogether.
the roles of BCL-6 is to direct B and T cells into close proximity as part of the multifaceted germinal centre response. More recently, FOXO transcription factors were shown to bind to a promoter site in the eomesodermin (Eomes) gene and to control its expression in differentiated CD8 + T cells 96 . Together, the known cell type-specific FOXO target genes profoundly affect the survival, homing, proliferation and differentiation of T cells. By targeting these genes, together with numerous other, more widely expressed genes, FOXO transcription factors control the immune system in varied and diverse ways 14 (TABLE 1) .
Role in T cell survival and cell-cycle progression
One of the characteristic features of FOXO transcription factors is their control of the cell cycle and apoptosis. Specifically, evidence has been presented that FOXO transcription factors (mainly FOXO3) positively control the expression of several cyclin-dependent kinase inhibitors, including p15 (also known as INK4B), p19 (also known as INK4D), p21 (also known as CIP1) and p27 (also known as KIP1), as well as that of the proapoptotic molecules BIM (also known as BCL2L11), PUMA (also known as BBC3) and FAS ligand (also known as CD95L) 3, 4, 29, [97] [98] [99] [100] . Most of these studies were carried out in non-lymphoid cell lines and so their relevance to T cells is not clear, although FOXO3 was shown to induce the expression of p27 and BIM in the CTLL cell line 3 and that of PUMA in T cells following the withdrawal of IL-2 (REF. 98 ). The concept is that signalling through growth-inducing receptors (such as the TCR or cytokine receptors) transiently activates the PI3K pathway, which inactivates FOXO transcription factors, and this is the primary signal promoting cell division and survival 101 . A caveat is that constitutively active AKT (as a result of a PTEN deficiency) does not completely rescue the loss of viability following IL-2 withdrawal 98 , and thus there may be redundant death pathways operative in T cells. In fact, FOXO1-and FOXO3-deficient naive T cells do not spontaneously enter the cell cycle, and mice with a haematopoietic deletion of Foxo1, Foxo3 and Foxo4 do not develop lymphomas until 22 weeks of age, with almost 75% of the mice remaining disease-free for 75 weeks 5 . A further complication is that FOXO1 seems to have a role distinct from that of FOXO3. FOXO1 promotes the survival of naive T cells through the expression of IL-7Rα and thus BCL-2 (REFS 66,68). Furthermore, CD4
+ but not CD8 + T cells require FOXO1 for antigenor mitogen-stimulated population expansion, both in culture and in vivo. In particular, following the acute deletion of Foxo1 and cell activation through CD3 and CD28, CD4 + T cells progress through multiple rounds of cell division, but undergo apoptosis at a very high rate (Y. Kerdiles and E.L.S., unpublished data). This defect in survival was not rescued by the transgenic expression of Il7ra, and the mechanism underlying a requirement for FOXO1 in T cell survival is currently unknown. Similar experiments with FOXO3-mutant T cells stimulated in vitro revealed no differences compared with wild-type T cells 43 . The unique roles for FOXO1 and FOXO3 in T cell survival and division have so far not been resolved; however, these studies suggest that FOXO1 expression is required for naive T cell survival and that its nuclear expression is attenuated, but not ablated, following T cell activation. By contrast, increased FOXO3 activity induced by a growth factor deficiency is pro-apoptotic. The underlying basis for these intricately controlled and opposing functions is presently unknown.
Changes in FOXO3 expression are apparent in T cells from HIV-infected patients. HIV induces the apoptosis of primary CD4 + T cells, and the presence of the HIV protein Tat alone is sufficient to recapitulate this effect. Tat was proposed to function through the activation of PTEN and FOXO3, and, given its propensity to cross the plasma membrane, it may not act in a cell-autonomous manner [102] [103] [104] . In addition, CD4 + memory T cells from HIV-infected individuals who control HIV replication (elite controllers) have increased amounts of phosphorylated FOXO3, and this is correlated with the increased survival of memory CD4 + T cells 105 . Another study showed that preventing FOXO3 phosphorylation in CD4 + central memory T cells increased apoptosis 106 . The proposed model is that an increase in FOXO3 activity, possibly owing to Tat signalling in patients with HIV, results in T cell apoptosis, whereas attenuation of FOXO3 through phosphorylation (as occurs in elite controllers) results in enhanced memory T cell survival. From this we conclude that the amount, localization, activity and specificity of FOXO transcription factors, as regulated by some or all of the mechanisms already described, are important in determining the outcome of an immune response. In particular, the balance between persistent pathogen infections and clearance may be influenced by the precise physiological state of the infected individual as interpreted by FOXO transcription factors.
Box 2 | Analysis of FOXO transcription factor target genes
Several criteria for identifying forkhead box O (FOXO) target genes can be used to assess the participation of FOXO transcription factors in lymphocyte-specific gene expression. One is the evolutionarily conserved presence of a FOXO-binding consensus motif in the promoter or enhancer regions of a gene of interest. A second criterion is the specific binding of FOXO transcription factors to such a site in T cells, as shown by electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (ChIP) or ChIP followed by sequencing (ChIP-seq) experiments. A third is the demonstration that a sequence containing the FOXO-binding consensus motif can function as an active regulatory region in T cell-specific reporter experiments. A fourth means of identifying a role for FOXO transcription factors in the transcriptional regulation of a particular gene is to show that acute genetic deletion of one or more FOXO genes results in the loss of target gene expression. The fifth commonly presented form of evidence is that constitutively nuclear mutant forms of FOXO transcription factors induce the expression of a given gene. Combinations of one or more of these criteria have identified several important FOXO target genes in T cells, but new technologies will undoubtedly establish target genes more definitively. Such an analysis would consist of global gene expression analyses (using a microarray or mRNA sequencing) with and without the acute deletion of a FOXO gene, ChIP-seq to identify FOXO-bound regulatory sequences (enhancers and silencers), and 3C techniques to identify the physical associations between regulatory sequences and 5ʹ proximal promoters 171, 172 .
Chromatin immunoprecipitation
(ChIP). An assay used to determine whether specific transcription factors are bound to chromatin. DNA-protein complexes are stabilized by reversible crosslinking, the DNA is sheared to an average size of about 500 bp, an antibody specific for a suspected chromatinassociated factor is used to carry out immunoprecipitation, and the complexes are isolated. Following dissolution of the crosslinks and protein digestion, PCR is used to determine whether specific DNA sequences were co-isolated. A positive signal using appropriate controls indicates that a given factor is within proximity (about 500 bp) of the primers used to amplify the DNA.
T Reg cell development and function Natural T Reg cell development. In addition to having defects in naive T cell survival and homing (owing to decreased expression of Il7Ra and Klf2) 66, 68, 83 , mice with a T cellspecific conditional mutation in Foxo1 have substantial immunopathology that is not cell autonomous but rather is associated with decreased numbers of FOXP3 + natural T Reg cells in the thymus 69, 86 . This diminution in numbers is even more pronounced when FOXO1-deficient T cell precursors have to compete with wild-type pre cursors in a mixed bone marrow chimaera 69 . Furthermore, mice lacking both FOXO1 and FOXO3 in T cells have few natural T Reg cells in the thymus and decreased T Reg cell numbers in secondary lymphoid organs when at a young age but have normal numbers of FOXP3 + T cells as adults. Mortality from excessive immunopathology was seen starting at 8 weeks of age, and experiments showed that FOXO1-deficient bone marrow cells were unable to complement a loss of FOXP3 in mixed bone marrow chimaeras. The conclusion drawn from these studies is that both the development and function of natural T Reg cells are retarded in the absence of FOXO1, with an additive contribution from FOXO3 (REFS 66, 86, 87) .
These results highlight the suggestion that FOXP3, although essential for T Reg cell function, is not a lineage specification factor. Studies have shown that it is only one of the essential transcription factors required for the development of a T Reg cell phenotype [107] [108] [109] [110] [111] . In fact, an analysis of genes expressed by various T Reg cells showed that FOXP3 expression positively correlated with the expression of only a small number of T Reg cell signature genes 108 . Additional studies indicate that the AKT-mTOR axis might regulate a substantial portion of the T Reg cell gene signature independently of FOXP3 (REFS 112, 113) . A conclusion of these studies was that a higher level of regulation, upstream of FOXP3, determines the T Reg cell lineage 108 , and one possibility is that FOXO transcription factors, which are inhibited by AKT, constitute an essential aspect of this higher level of control.
Induced T Reg cell development. Mature naive CD4 + FOXP3
− T cells can give rise to induced T Reg cells in the presence of transforming growth factor-β (TGFβ) 114 . When naive CD4 + T cells lacking FOXO1 or both FOXO1 and FOXO3 were cultured in this manner, few FOXP3 + induced T Reg cells developed 69, 86, 87 . FOXO3-deficient CD4 + T cells also showed a decreased ability to develop into induced T Reg cells, although the effect was less pronounced than for FOXO1 deficiency 87 . Although there are some discrepancies, in general conditions that favour activation of the PI3K-AKT pathway retard the differentiation of induced T Reg cells, whereas inhibition of the PI3K-AKT pathway promotes T Reg cell differentiation 87, 112, [115] [116] [117] [118] [119] . We thus propose that inhibition of PI3K-AKT signalling is specifically Exons:
ChIP-seq
An assay similar to chromatin immunoprecipitation (ChIP) with the exception that the immunoprecipitated DNA is modified by the addition of coded oligonucleotides, and the resulting libraries of DNA are sequenced using massively parallel sequencing techniques.
mRNA sequencing
In this technique, poly(A)-containing mRNA isolated by hydridization to oligo-dT columns may be fragmented and is then converted to complementary DNA (cDNA) using the enzyme reverse transcriptase. The cDNA is then prepared for parallel sequencing. required for the nuclear localization and activity of FOXO transcription factors 69 . This is also in accord with the activity of vitamin A metabolites and vitamin D, both of which have been shown to induce nuclear localization of FOXO transcription factors in myeloid leukaemia and squamous carcinoma cells 116, 120 and, in separate studies, the induction of T Reg cells [121] [122] [123] . At the heart of these effects is the mTOR pathwaythe master regulator of protein synthesis 124, 125 . mTOR forms two distinct kinase complexes, mTORC1 and mTORC2, and these complexes are intricately related in terms of their activity as well as their structure 126 . mTORC1 is activated downstream of AKT by the inhibitory phosphorylation of the mTORC1 inhibitor, tuberous sclerosis protein 2 (TSC2). Activated mTORC1 promotes protein translation in several ways, including through an increase in ribosome biogenesis (FIG. 1) . We can therefore deduce that this would sequentially activate mTORC2, stabilize AKT and thus lead to inactivating phosphorylations of FOXO transcription factors.
Genetic or pharmacological inhibition of mTOR leads to the generation of induced T Reg cells in the absence of added cytokines, and naive T cells in which mTOR is inhibited do not differentiate into T helper 1 (T H 1), T H 2 or T H 17 cells 127 . In particular, rapamycinwhich inhibits mTORC1 and, with prolonged application, mTORC2 -causes activated T cells to differentiate into T Reg cells 113, [128] [129] [130] . Likewise, a T cell-specific deletion of the gene encoding mTOR causes activated T cells to assume a T Reg cell phenotype 131 . Furthermore, mTOR signalling is decreased when the availability of essential amino acids is limited, and this decrease synergizes with TGFβ in promoting the differentiation of induced T Reg cells 132 . Genetic ablations leading to the individual loss of mTORC1 or mTORC2 are not sufficient to cause T Reg cell differentiation, implying that both pathways have to be abrogated for T Reg cell differentiation to occur 131 . We conclude that T Reg cell differentiation requires the inhibition of mTOR signalling, and we propose that this is mediated in part through an increase in the nuclear localization and activity of FOXO transcription factors.
Mechanisms of FOXO transcription factors in the function of T Reg cells.
The mechanisms underlying the requirement for FOXO transcription factors in T Reg cell differentiation are not yet understood. The simplest idea is that FOXO transcription factors are required for the transcription of Foxp3, as studies have shown that FOXO transcription factors can bind to and transcriptionally activate a previously mapped Foxp3 promoter sequence 86, 87 (FIG. 4) . However, we found that T Reg cells are present in the secondary lymphoid organs of adult Foxo1 −/− Foxo3 −/− mice and have only slightly decreased FOXP3 expression 69 . Nonetheless, these cells are not sufficient to prevent immunopathology 69, 86 . As T Reg cells are all but absent in the thymus in the absence of Foxo1 and Foxo3, we deduce that a small number of FOXP3 + T Reg cells proliferate over time to produce T Reg cells in normal numbers. One proposal is that FOXO transcription factors together with REL (which binds to the CNS3 enhancer in Foxp3) facilitate chromosome accessibility within the Foxp3 locus 133 to promote the eventual accumulation of other transcription factors 133 (FIG. 4) 136 and, notably, FOXP3 itself, which implies self-reinforcing gene expression 18, 133 . Without REL or FOXO factors, the Foxp3 locus might be relatively inaccessible, but over time it could achieve close to full activity owing to this self-reinforcing mechanism.
Given the presence of FOXP3 + T cells in secondary lymphoid organs, what is the basis for the immunopathology seen in mice deficient for FOXO1 and FOXO3? It does not seem to be intrinsic to the expanded populations of effector T cells, but rather results from a lack of T Reg cell function. Thus, one possibility is that a small diminution of FOXP3 expression is sufficient to handicap the extant T Reg cells. Another possibility is that, in the absence of FOXO transcription factors, FOXP3 + T Reg cells lack the suppressive function required for immune quiescence. Consistent with this idea, active AKT prevents FOXP3 + T Reg cell differentiation, whereas it does not affect established FOXP3 expression in T Reg cells 112 . Another study has shown that enforced expression of an active allele of AKT in human CD4 + CD25 + T cells (which is presumed to constrain FOXO activity) inhibits their suppressive function 137 . In addition, FOXP3 + T Reg cells that are deficient in both FOXO1 and FOXO3 are less efficient than wild-type cells in a suppression assay in cell culture 86 . One key feature of T Reg cells is their expression of CTLA4, an indispensable co-receptor for T Reg cell function [138] [139] [140] . We found that FOXO1 is required for CTLA4 expression (whether directly or indirectly) in all T cells tested, and it binds to a DBE located 193 base pairs upstream of the Ctla4 transcriptional start site 69 . Although there are likely to be other genes crucial for T Reg cell function that are under the control of FOXO transcription factors, the requirement for FOXO1 in CTLA4 expression would itself be sufficient to explain the immunopathology seen in both Foxo1
−/− and Foxo1 −/− Foxo3 −/− mutant mice. . The enhancer nomenclature for Foxp3 is from REF. 133 . CBFβ, core-binding factor-β; CREB, cAMP-responsive element-binding protein; NF-κB, nuclear factor-κB. *Evolutionarily conserved DAF-16 binding elements.
3C techniques
Chromosome conformation capture (3C) is used to determine whether a distal enhancer sequence is in proximity to a promoter in a given state of a particular cell type. The basic concept is that DNA-protein and proteinprotein interactions in the nucleus are reversibly crosslinked to stabilize interacting regions of DNA. The DNA is digested to completion with a restriction enzyme, and intramolecular ligation is carried out to link promoter and enhancer sequences. The resulting complex can be analysed by sequencing in several ways to identify known or unknown interacting regulatory elements.
mTORC1
(Mammalian target of rapamycin complex 1). A complex consisting of: mammalian target of rapamycin (mTOR), which is a serine/threonine kinase; regulatory-associated protein of mTOR (RAPTOR); prolinerich AKT substrate of 40 kDa (PRAS40), which is an mTORC1 inhibitor; mLST8 (also known as GβL), which is of unknown function; and DEP domaincontaining mTOR-interacting protein (DEPTOR), which is an mTOR inhibitor.
CNS3 enhancer
One of four DNA regulatory regions in the Foxp3 gene (together with the promoter, CNS1 and CNS2) that was initially defined by histone modifications that are permissive for transcription. CNS1, CNS2 and CNS3 were then analysed for activity by generating mice with deletions spanning each region of the chromosome.
Cd4Cre Foxo1
f/f mice
Mice in which both alleles of the Foxo1 gene are modified to include loxP sites flanking exon 2 and in which the Cre recombinase gene from the P1 bacteriophage is expressed from a transgene using control elements of the Cd4 gene. In such mice, the Foxo1 gene is inactivated in the T cell lineage during the CD4 + CD8 + stage of thymic development.
T H 1 cell differentiation
Recently, the mTOR-FOXO pathway has emerged as a key pathway regulating T H 1 cell versus T Reg cell differentiation. S1P 1 (which is encoded by S1pr1) activates AKT and also activates S6 kinases downstream of the mTORC1 pathway. Experiments have shown that a lossof-function mutation in S1pr1 promotes T Reg cell development, whereas an S1pr1 gain-of-function mutation inhibits the differentiation of induced T Reg cells. Instead, under conditions that promote T Reg cell induction in wild-type T cells (such as the presence of TGFβ), the presence of an S1pr1 transgene diverted naive T cell differentiation towards the generation of T H 1 cells 141, 142 . In particular, the ability of TGFβ to maintain the phosphorylation of SMAD3 for between 24 and 48 hours and to induce T Reg cells was lost in the presence of the S1pr1 transgene. A conclusion based on these results could be that S1P 1 69 . As SMAD proteins form transcriptional complexes with FOXO transcription factors 4 , the loss of sustained SMAD3 phosphorylation at later times may be indirect and result from the inactivation of FOXO1 through S1P 1 signalling. We conclude that, under some conditions, T H 1 cells and T Reg cells constitute alternative fates that depend on S1P 1 signalling, mTOR activation and FOXO transcription factor activity.
T follicular helper cells FOXO transcription factors clearly have a role in regulating the differentiation of CD4 + T cells into T Reg cells and T H 1 cells; however, the potential role of FOXO transcription factors in regulating the differentiation of other T cell subsets is just beginning to be studied. Mice with a T cell-specific deletion of Foxo1 spontaneously accumulate a large number of CXCR5 + PD1 + T FH cells, and this corresponds with the appearance of germinal centres, class-switched B cells and DNA-specific antibodies 69 . The differentiation of T FH cells from naive CD4 + T cells normally depends on signalling through the co-stimulatory molecule inducible T cell costimulator (ICOS) and on sequential antigen presentation by DCs and B cells [143] [144] [145] [146] . Signalling through ICOS is dependent on PI3K, such that a mutation in the cytoplasmic tail of ICOS that prevents PI3K recruitment decreases T FH cell development 147 . Furthermore, mice with a T cell-specific deletion of the gene encoding the p110γ subunit of PI3K have greatly decreased numbers of T FH cells after immunization with foreign proteins adsorbed to alum adjuvant 148 . These studies clearly establish the role of the ICOS and PI3K pathway in the differentiation or survival of T FH cells and, on the basis of the emergence of T FH cells in Cd4Cre Foxo1 f/f mice, we speculate that a role of ICOS signalling is to inactivate FOXO transcription factors. However, as described above, FOXO3 has been shown to positively regulate the expression of BCL6, which encodes the essential transcription factor for T FH cell differentiation [91] [92] [93] . Thus, the enigma is that in some cells FOXO3 positively regulates BCL-6, even though ICOS signalling (which is required for T FH cell differentiation) would be predicted to negatively regulate all FOXO transcription factors. A recent study showed that strong IL-2 signalling inhibits the expression of a profile of T FH cell-associated genes, including Bcl6, and this was correlated with decreased binding of FOXO1 to the Bcl6 promoter 149 . The manner by which FOXO1 regulates BCL-6 expression, and how this relates to ICOS signalling and T FH cell differentiation, requires further study.
CD8
+ T cell differentiation and function Following host infection with an intracellular pathogen, antigen-specific naive CD8 + T cells accumulate in draining lymphatic organs, proliferate and differentiate into effector T cells. The expanding T cell population diversifies, such that a small proportion of cells acquires characteristics of memory cell precursors, whereas most cells maintain an effector phenotype. At the peak of the expansion phase (usually around 8 days after infection in mouse models of acutely infectious agents), this T cell diversity is evident on the basis of the differential expression of key cell-surface molecules. Memory precursor effector cells have a KLRG1 low CD127
hi phenotype, whereas effector cells have a KLRG1 hi CD127 low phenotype 150, 151 . The differentiation of activated T cells into T cell memory precursors and then long-lived memory T cells is thought to be based on a progressive and selfreinforcing programme of gene expression that may originate with stochastic changes in the expression of a few genes [150] [151] [152] [153] . One part of this gene expression programme is the transcription factor EOMES 154, 155 , and EOMES expression depends on WNT-mediated conversion of the transcription factor TCF7 (also known as TCF1) into an active complex with β-catenin 156, 157 . As described earlier, FOXO1 regulates programmes of homing, self-renewal, cell-cycle entry and progression, and cell survival, all of which are essential components in the control of memory versus effector T cell differentiation. In accord with this, recent work has shown that FOXO1 and FOXO3 might each have a role in CD8 + T cell differentiation. CD8 + T cells acquire some of the hallmarks of effector function (such as a KLRG1 hi phenotype) through the expression of Tbx21 (which encodes T-bet), and this is amplified by antigeninduced stimulation in the presence of IL-12 (REF. 152 ). Reminiscent of the role of FOXO1 in the TGFβ-mediated inhibition of T-bet 69 , a recent study showed that IL-12 promotes Tbx21 expression by inactivating FOXO1, and Tbx21 expression can be inhibited indirectly by FOXO1 overexpression 96 . Furthermore, FOXO1 seems to directly target Eomes, and thus constitutes a second pathway that converges on Eomes expression in order to promote a memory cell phenotype. T cells that were adoptively transferred following in vitro activation and knockdown of Foxo1 expression survived poorly after 40 days and showed no ability to be reactivated in vivo 96 . Thus, FOXO1 activity may be at least one deciding factor in effector versus memory precursor CD8 + T cell differentiation. This is consistent with a report describing the effects of sustained AKT activation in CD8 + T cells, a condition that would induce the inactivation of FOXO1. Indeed, these cells had decreased levels of EOMES and TCF7 and a reduced potential to survive and adopt a memory phenotype compared with control cells 158 . These studies may help to explain the mechanism underlying the ability of metformin or rapamycin to promote CD8 + memory T cell formation 159, 160 . Both drugs inhibit the mTORC1 and mTORC2 pathways [161] [162] [163] and, as such, they might function in part or even entirely through their ability to promote FOXO transcription factor activity.
Other studies have shown that the maintenance of a memory T cell phenotype is an active process dependent on T cell interactions with DCs, and these interactions are mediated through CD27 and 4-1BB 164 . CD27 signalling correlates with decreased FOXO1 activity, leading to the conclusion that inhibition of FOXO1 is required for the maintenance of a memory T cell phenotype. Although this might seem to be inconsistent with the role of FOXO1 inactivation in inducing an effector T cell phenotype, these studies probe different stages in T cell differentiation. The exact amount of nuclear FOXO1, its available cofactors and its post-translational modifications might differ between newly emerging activated CD8 + T cells and long-term memory T cells. Experiments also support a role for FOXO3 in CD8 + T cell proliferation. In our studies, there was a clear increase in the expansion of CD8 + T cell populations in FOXO3-deficient mice, but at early time points we found the increase to originate with the DC population. In the absence of FOXO3, DCs produced excess IL-6, TNF and CC-chemokine ligand 2 (CCL2; also known as MCP1), and the additional IL-6 was sufficient to cause higher than normal levels of T cell population expansion owing to an increase in survival 43 . However, a more recent study showed that in mice with a T cell-specific deletion of Foxo3, there was up to a twofold increase in the number of antigen-specific T cells present in the spleen at day 8 after virus infection 67 . Furthermore, one possibility is that FOXO1 and FOXO3 have overlapping, but possibly distinct, functions in CD8 + T cell proliferation and differentiation, and future studies will elucidate the specific programmes of gene expression mediated by these two paralogues.
Conclusion
In almost every aspect of T cell biology so far examined, there is a role for FOXO transcription factors. They respond to a wide range of extrinsic signals to fundamentally alter the trajectory of a T cell-dependent immune response. The programmes of gene expression affected include cell type-specific genes involved in differentiated functions, as well as genes that control the essential aspects of general cellular physiology, such as cell division, survival and metabolism. The challenge will be to isolate the direct effects of FOXO transcriptional regulation from the indirect effects that ripple and echo throughout the signalling network of the cell. Given the right antibodies or tagged versions of FOXO transcription factors, the technology is now available to definitively characterize the FOXO1 and FOXO3 gene targets at each stage of T cell differentiation.
To what end? In addition to providing a map of gene connections, we contend that such an analysis will unveil the relationships between inflammation, metabolism and oxidative stress, and the manner by which these conditions affect the strength and effectiveness of an immune response. How does hyperinsulinaemia affect the course of an acute, persistent or latent infection? Do pathogens that provoke an oxidative burst experience a different response from those that elicit high levels of inflammation? Do these physiological changes act directly on T cells, or are the effects on DCs and macrophages more important? We think that a broad analysis of the part played by FOXO transcription factors in the immune system will illuminate and eventually bring resolution to these issues of medical significance.
